News & Events about Bionano Genomics Inc.
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the launch of OGM-Dx HemeOne, a laboratory developed test (LDT) based on optical genome mapping (OGM) analysis of blood or bone marrow samples to detect structural variants (SVs) of diagnostic and prognostic utility in...
Bionano Prep SP-G2 (SP-G2) kit offers higher gDNA quality, improved ease-of-use and increased DNA throughputBionano Prep Direct Label and Stain-G2 (DLS-G2) kit offers increased reagent stability and labeling efficiency resulting in significantly faster sample to results workflowSaphyr Chip G3.3, ...
27 different customers representingNorth AmericaandEurope30 oral presentations across four consecutive days34 scientific posters will be featured in a virtual exhibition hallTopics span the application of optical genome mapping (OGM) in genetic disease, cancer research and cell bioprocessing SAN ...
IRB-approved, multi-site, ongoing study evaluated 200 samples representing 123 unique prenatal cases across 9 sites for interim measures of key endpoints: Results of OGM analysis were comparable, in a single assay, to the results of two separate standard of care (SOC) tests needed to reach a ...
SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc.(Nasdaq: BNGO) today announced a collaboration with NVIDIA to develop an acceleration platform for use in Bionanos optical genome mapping (OGM) workflow. This collaboration is expected to significantly improve data processing speed ...